孙美珍 田林华 迟家敏 100730 北京医院内分泌科 中华内科杂志 1998 0 37 6


    关键词： 期刊 zhnkzz 0 糖尿病，非胰岛素依赖型血脂康 fur -->


    

【摘要 】 目的 验证血脂康对Ⅱ型糖尿病患者糖、脂代谢的影响。方法 100例Ⅱ型糖尿病在原降糖措施的基础上分为四组，不合并(A组)和合并(B组)高脂血症各30例加服血脂康，不合并(C组)和合并(D组)高脂血症各20例不服血脂康为对照组，疗程2个月。结果 A、B两组分别降低空腹血糖7.6%±7.7%和10.8%±9.6%，餐后2小时血糖14.1%±9.0%和12.2%±10.5%，糖化血红蛋白A₁ c 11.0%±5.4%和6.3%±7.8%，总胆固醇9.0%±9.0%和15.0%±9.0%，甘油三酯4.0%±13.0%和21.0%±26.0%，与治疗前相比，差异有非常显著性(P值分别<0.05和<0.01)，C、D组在观察前后各项指标无明显变化(P值均>0.05)。未见副作用。结论 血脂康对Ⅱ型糖尿病除可调节异常血脂外，尚有一定降低血糖的作用。

The effect of Xuezhikang on glucose and lipid metablism in type Ⅱ diabetes mellitus Sun Meizhen, Tian Linhua, Chi Jiamin. Beijing Hospital, Beijing 100730

     【 Abstract 】 Objective To confirm the effect of Xuezhikang on glucose and lipid metablism in type Ⅱ diabetes mellitus. Methods 100 cases of type Ⅱ diabetes mellitus patients were divided into four groups based on previous hypoglycemic. 30 cases with (group B) and without (group A) hyperlipidemia respectively took 2 capsules of Xuezhikang twice a day for two months. 40 cases matchabe with group A and B serving as controls took no Xuezhikang. Results Fasting glucose decreased by 7.6%±7.7% and 10.8%±9.6%, 2-hour postprandial blood glucose by 14.1%±9.0% and 12.2%±10.5%, GHbAlc by 11.0%±5.4% and 6.3%±7.8%, serum total cholesterol by 9.0%±9.0% and 15.0%±9.0% triglyceride by 4.0%±13.0% and 21.0%±26.0% in group A and B respectively. The parameters after treament were significantly different from those before treatment. In group C and D there was no change of the parameters before and after observation. No side effects were found in those who took Xuezhikang. Conclusion Xuezhikang can not only adjust dyslipidemia, but also have some effects on ameliorating hyperglycemia in type Ⅱ diabetes mellitus.

     【 Key words 】 Diabetes mellitus, non-insulin-dependent Xuezhikang

自1995年血脂康问世以来仅仅2年间 ......

    百拇医药网 http://www.100md.com/html/DirDu/2005/07/06/65/05/89.htm

您现在查看是摘要页，全文长 35640 字符。